Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies.
about
Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studiesAripiprazole long-acting injectable formulations for schizophrenia: aripiprazole monohydrate and aripiprazole lauroxil.Adherence to antipsychotic medication among homeless adults in Vancouver, Canada: a 15-year retrospective cohort study.Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits.Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review.A longitudinal analysis of the overlap between violence and victimization among adults with mental illnesses.How should a virtual agent present psychoeducation? Influence of verbal and textual presentation on adherence.Medication nonadherence among South American patients with schizophrenia.Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments.Effect of a Telephone Intervention Upon Self-Reported Medication Adherence and Self-Efficacy in Outpatients With Schizophrenia Spectrum Disorders (SSDs).Continue, adjust, or stop antipsychotic medication: developing and user testing an encounter decision aid for people with first-episode and long-term psychosis.Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis
P2860
Q24289439-938CE312-FF75-4A31-A826-44B96A23E1BDQ34501911-D77A1BAA-A3FE-4CAD-AECF-CFD5C7C4C195Q37388354-F35629FA-0D04-4BF2-85AE-DB55D706DBF5Q38624500-C82C0953-40F8-4A13-8646-A9D664774A63Q38851847-14AFF59E-9E53-44B2-BE8D-1E5DD9CEC770Q38852539-4414BACC-81C0-4A13-A647-5B580C0A5341Q40411482-46BC1D32-616F-4851-B2B9-E12B5474A775Q40495104-61E28D77-FEDE-4F48-BD0A-92EAA5ABBB7BQ42701502-C5E411F7-E20E-4490-8641-753EC4BFD2CEQ47553805-9F298DDD-4745-48E1-ABFC-238F482B9EC1Q54745596-14235C3E-6E9D-4DDA-9FEB-449761EFAD59Q55449451-B60A2E7D-39ED-4277-A473-540A01C41097Q58760344-51F23079-21FB-426B-8E4D-0AE5311ACA00
P2860
Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Treatment adherence in schizop ...... ined CATIE and EUFEST studies.
@en
type
label
Treatment adherence in schizop ...... ined CATIE and EUFEST studies.
@en
prefLabel
Treatment adherence in schizop ...... ined CATIE and EUFEST studies.
@en
P2093
P2860
P1476
Treatment adherence in schizop ...... ined CATIE and EUFEST studies.
@en
P2093
Jan Volavka
Pál Czobor
Richard A Van Dorn
W Wolfgang Fleischhacker
P2860
P304
P356
10.1016/J.EURONEURO.2015.04.003
P407
P577
2015-04-30T00:00:00Z